Jaideep Dudani is the founder of Ouro Medicines. Ouro Medicines has raised $120M in total funding. Latest round: Series A. Based in San Francisco, California.
Jaideep Dudani is the CEO of Ouro Medicines, a biotechnology company founded by Monograph Capital in partnership with GSK. Ouro Medicines focuses on developing immune reset therapeutics, specifically novel T cell engagers, for chronic immune-mediated diseases. The company launched with $120 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library